Assem Sabry

Medical AI Research

Explore Assem Sabry's research and projects in the medical field, focusing on AI-powered diagnostic tools and healthcare solutions that bridge the gap between artificial intelligence and medical practice.

IBTD Logo

Intelligent Brain Tumor Detector (IBTD)

Overview

The Intelligent Brain Tumor Detector (IBTD) is a deep learning-based classifier built to accurately detect and classify brain tumor types from MRI images. The model is trained using a fine-tuned ResNet50 architecture and leverages modern training techniques like data augmentation and MixUp regularization.

Model Evaluation Report

The model was evaluated on a balanced test set containing four brain tumor categories: GLIOMA, MENINGIOMA, NOTUMOR, and PITUITARY.

Classification Performance:

ClassPrecisionRecallF1-scoreSupport
GLIOMA99.65%95.00%97.27%300
MENINGIOMA93.87%95.10%94.48%306
NOTUMOR99.26%99.51%99.38%405
PITUITARY96.44%99.33%97.87%300

Overall Accuracy: 98.41%

IBTD Banner

Technical Implementation

Model Architecture

  • • Fine-tuned ResNet50 architecture
  • • Data augmentation techniques
  • • MixUp regularization
  • • Multi-class classification (4 classes)

Performance Metrics

  • • Overall accuracy: 98.41%
  • • Balanced test set evaluation
  • • High precision across all classes
  • • Robust recall performance
HAID Logo

Histopathological AI Detection (HAID)

Overview

HAID (Histopathological AI Detection) is an AI-powered deep learning model developed to detect breast cancer in histopathological images. It's designed to assist medical professionals with faster, more consistent diagnoses, empowering hospitals and pathology labs with intelligent diagnostic tools.

Dataset

Dataset Specifications

  • Images: Over 250,000 high-resolution histopathological samples
  • Classes: Binary classification: Normal vs. Cancer
  • Image Size: All images resized to 150x150 pixels
HAID

Model Performance

Validation Accuracy: ~80% (to be updated after final evaluation)

Classification Report:

ClassPrecisionRecallF1-Score
Normal78.3%80.0%79.1%
Cancer81.2%79.5%80.3%